Renin-Angiotensin System Inhibitors in Patients With Nonproteinuric Chronic Kidney Disease and Kidney Outcomes: Findings From the CRIC Study
For people with nonproteinuric CKD, RASIs may not be kidney-protective but may still confer a mortality benefit for hypertension management.
Authors
- Mahboob Rahman (ORCID: https://orcid.org/0000-0001-9025-7413)
- Harold I. Feldman (ORCID: https://orcid.org/0000-0003-4572-2608)
- Mark L. Unruh (ORCID: https://orcid.org/0000-0001-7103-656X)
- Lawrence J. Appel (ORCID: https://orcid.org/0000-0002-0673-6823)
- Peter P. Reese (ORCID: https://orcid.org/0000-0003-1440-069X)
- James Phillip Lash (ORCID: https://orcid.org/0000-0002-6580-4080)
- Vallabh O. Shah (ORCID: https://orcid.org/0000-0002-3584-4057)
- Jing Chen (ORCID: https://orcid.org/0000-0001-9409-157X)
- R S Shulman (ORCID: https://orcid.org/0000-0003-4890-9275)
- Jordana B. Cohen (ORCID: https://orcid.org/0000-0003-4649-079X)
- Wei Peter Yang (ORCID: https://orcid.org/0000-0001-8984-4389)
- Alan S. Go
- Panduranga S. Rao
- Debbie L. Cohen
- Robert G. Nelson
Publication Details
- Journal
- Kidney Medicine
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1016/j.xkme.2025.101159
- Citations
- 1
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Vanderbilt University
- University of Pennsylvania
- Vanderbilt University Medical Center
- Perelman School of Medicine, University of Pennsylvania